To evaluate the effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma (POAG) by means of an obseiver-masked, prospective clinical study.
METHODS
Thirty-two patients with newly diagnosed POAG were included in the study. The patients were randomized into two groups. The first group was treated with betaxolol 0.50% twice daily and the second group with latanoprost 0.005% once daily. Baseline and post-treatment examinations on the first and third months of treatment included intraocular pressure (IOP) measurement, automated visual field testing, and ocular blood flow assessment. For evaluation of visual fields, mean defect and pattern standard deviation indices were used. Ocular blood flow was assessed by means of color Doppler imaging of the central retinal artery (CRA) and the temporal short posterior ciliary artery (PCA). For each vessel, peak systolic (PSV) and end-diastolic (EDV) blood flow velocities were measured and resistivity index (RI) calculated.
Results
After exclusion of one noncompliant patient, the study was completed with 31 eyes of 31 patients. Both drugs significantly reduced IOP (p<0.05). The mean IOP lowering effect of latanoprost was significantly higher than that of betaxolol (p=0.03). Visual field indices exhibited no significant changes in either group (p>0.05). There were no significant changes in PSV or EDV measurements of CRA or PCA in either group (p>0.05). RI decreased in both CRA and PCA with both drugs. The mean changes between baseline and 3 month blood flow measurements were not significantly different between betaxolol and latanoprost (p>0.05).
CONCLUSIONS
Over a treatment period of 3 months, both betaxolol and latanoprost tended to improve ocular blood flow without one of them being superior to the other. The results suggest that the direct (non IOP-dependent) influence on ocular circulation is better for betaxolol than for latanoprost. In addition, neither drug caused significant generalized improvements in visual fields during this period.
The Advanced Glaucoma Intervention Study (AGIS):7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators.Am J Ophthalmol2000; 130: 429–40.
2.
HeijlA., LeskeC.L., BengtssonB., HymanL., BengtssonB., HusseinM., for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression.Arch Ophthalmol2002; 120: 1268–79.
3.
RankinS.J.A.. Color Doppler imaging of the retrobulbar circulation in glaucoma.Surv Ophthalmol1999; 43(suppl): S176–82.
4.
SoltauJ.B., ZimmermanT.J.. Changing paradigms in the medical treatment of glaucoma.Surv Ophthalmol2002; 47(suppl): S2–5.
5.
FlammerJ., OrgülS., CostaV.P.The impact of ocular blood flow in glaucoma.Prog Retin Eye Res2002; 21: 359–93.
6.
NicolelaM.T., DranceS.M., RankinS.J.. Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss.Am J Ophthalmol1996; 121: 502–10.
7.
TuraçliM.E., ÖzdenR.G., BardakY., YazicioğluK.M.. Normal tansiyonlu glokomda betaksololün görme alani ve okuler kan akimi üzerindeki erken dönem etkisi.T Klin Oftalmoloji1995; 4: 345–9.
8.
HarrisA., SpaethG.L., SergottR.C., KatzJ.L., CantorL.B., MartinB.J.. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma.Am J Ophthalmol1995; 120: 168–75.
9.
Boles CareniniA.B., SibourG., Boles CareniniB.. Differences in the long term effect of timolol and betaxolol on the pulsatile ocular blood flow.Surv Ophthalmol1994; 38(suppl): S118–24.
10.
HosteA.M.. In vitro studies of the effects of ß-adrenergic drugs on retinal and posterior ciliary microarteries.Surv Ophthalmol1999; (Suppl): S183–90.
11.
HesterR.K., ChenZ., BeckerE.J., McLaughlinM., De-SantisL.. The direct vascular relaxing action of betaxolol, Carteolol and timolol in porcine long posterior ciliary artery.Surv Ophthalmol1994; 38: (Suppl): S125–34.
12.
GuptaA., ChenH.C., RassamS.M.B., KohnerE.M.. Effect of betaxolol on the retinal circulation in eyes with ocular hypertension study.Eye1994; 8: 668–71.
13.
HesseR.J.. Color Doppler ultrasound measurement of beta-blocker response in normal tension glaucoma.Neuro-Ophthalmol1995; 15: 259–63.
14.
GeorgopoulosG.T., DiestelhorstM., FisherR., RuokonenP., KrieglsteinG.K.. The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow.Acta Ophthalmol Scand2002; 80: 54–8.
15.
TamakiY., NagaharaM., AraieM., TomitaK., SandohS., TomidokoroA.. Topical latanoprost and optic nerve head and retinal circulation in humans.J Ocul Pharmacol Ther2001; 17: 403–11.
16.
IshiiK., TomidokoroA., NagaharaM.Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.Invest Ophthalmol Vis Sci2001; 42: 2957–63.
17.
GeyerO., ManO., WeintraubM., SilverD.M.. Acute effects of latanoprost on pulsatile ocular blood flow in normal eyes.Am J Ophthalmol2001; 131: 198–202.
18.
SponselW.E., MensahJ., KielJ.W.Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.Am J Ophthalmol2000; 130: 151–9.
19.
McKibbinM., MenageM.J.. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.Eye1999; 13: 31–4.
20.
VetrugnoM., CantatoreF., GiganteG., CardiaL.. Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow.Acta Ophthalmol Scand1998; 227(suppl): S40–1.
21.
LiuC.J., KoY.C., ChouJ.C., HsuW.M., LiuJ.H.. Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma.Br J Ophthalmol2002; 86: 1236–9.
22.
AburnN.S., SergottR.C.. Orbital colour Doppler imaging.Eye1993; 7: 639–47.
23.
GreeenfieldD.S., HeggerickP.A., HedgesT.R.III. Color Doppler imaging of normal orbital vasculature.Ophthalmology1995; 102: 1598–605.
24.
GuthoffR.F., BergerR.W., WinklerP., HelmkeK., ChumbleyL.C.. Doppler ultrasonography of the ophthalmic and central retinal vessels.Arch Ophthalmol1991; 109: 532–6.
25.
LiebW.E., CohenS.M., MertonA.D., ShieldsJ.A., MitchellD.G., GoldbergB.B.. Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy.Arch Ophthalmol1991; 109: 527–31.
26.
WilliamsonT.H., HarisJ.A.. Color Doppler ultrasound imaging of the eye and orbit.Surv Ophthalmol1996; 40: 255–67.
27.
TuraçliM.E., ÖzdenR.G., GürsesM.A.. The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucoma.Eur J Ophthalmol1998; 8: 62–6.
28.
RankinS.J., DranceS.M., BuckleyA.R., WalmanB.E.. Visual field correlations with color Doppler studies in open angle glaucoma.J Glaucoma1996; 5: 15–21.
29.
HarrisA., WilliamsonT.H., MartinB.. Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels.J Glaucoma1995; 4: 281–6.
30.
KaiserH.J., SchötzauA., FlammerJ.. Blood-flow velocities in the extraocular vessels in normal volunteers.Am J Ophthalmol1996; 122: 364–70.
31.
TalusanE.D., SchwartzB., WilcoxL.M.. Fluorescein angiography of the optic disc.Arch Ophthalmol1980; 98: 1579–87.
32.
HitchingsR.A., SpaethG.L.. Fluorescein angiography in chronic simple and low-tension glaucoma.Br J Ophthalmol1977; 61: 126–32.
33.
SpaethG.L.. Fluorescein angiography: its contributions towards understanding the mechanisms of visual loss in glaucoma.Trans Am Ophthalmol Soc1975; 73: 491–553.
34.
KaiserH.J., FlammerJ., StumpfigD., HendricksonP.. Long-term visual field follow-up of glaucoma patients treated with beta-blockers.Surv Ophthalmol1994; 38(suppl): S156–9.
35.
MontanariP., MarangoniP., OldaniA., RatigliaR., RaiteriM., BerardinelliL.. Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and Carteolol 2%.Eur J Ophthalmol2001; 11: 240–4.
36.
MessmerC., FlammerJ., StumpfigD.. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.Am J Ophthalmol1991; 112: 678–81.
37.
HosteA.M., SysS.U.. The relaxant action of betaxolol on isolated bovine retinal microarteries.Curr Eye Res1994; 13: 483–7.
38.
DranceS.M.. A comparison of the effects of betaxolol, timolol and pilocarpine on visual function in patients with open-angle glaucoma.J Glaucoma1998; 7: 247–52.
39.
AraieM., AzumaI., KitazawaY.. Influence of topical betaxolol and timolol on visual fields in Japanese open-angle glaucoma patients.Jpn J Ophthalmol2002; 47: 199–207.
40.
RainerG., DornerG.T., GarhoferG., VassC., PflegerT., SchmettererL.. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.Ophthalmologica2003; 217: 288–93.
41.
HosteA.M.. Reduction of IOP with latanoprost.Ophthalmology1997; 104: 895–7.
42.
RuloA.H., HoyngP.F.J.. Authors reply to letter of A. Hoste.Ophthalmology1997; 104: 896–7.
43.
KimuraT., YoshidaY., TodaN.. Mechanisms of relaxation induced by prostaglandins in isolated canine uterine arteries.Am J Obstet Gynecol1992; 167: 1409–16.
44.
MaigaardS., FormanA., AndersonnK.E.. Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit.Acta Physiol Scand1986; 128: 33–40.
45.
AstinM.. Effect of prostaglandin E2, F2α, and latanoprost acid on isolated ocular blood vessels in vitro.J Ocul Pharmacol Ther1998; 14: 119–28.
46.
StjernschantzJ., SelenG., AstinM., KarlssonM., ResulB.. Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye.Arch Ophthalmol1999; 117: 1363–7.
47.
BrogioloG., FlammerJ., HaefligerI.O.. Latanoprost is a vasoconstrictor in isolated porcine ciliary arteries.Klin Monatsbl Augenheilkd2001; 218: 373–5.
48.
NicolelaM.T., BuckleyA.R., WalmanB.E., DranceS.M.. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.Am J Ophthalmol1996; 122: 784–9.
49.
MauriceD.M.. Drug delivery to the posterior segment from the drops.Surv Ophthalmol1999; 47(suppl): S41–58.
50.
SponselW.E., TerryS., KhuuH.D., LamK.W., FrenzelH.. Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy.Surv Ophthalmol1999; 43(suppl): S210–3.
51.
TribleJ.R., SergottR.C., SpaethG.L.. Trabeculectomy is associated with retrobulbar hemodynamic changes: a color Doppler analysis.Ophthalmology1994; 101: 340–51.
